Novo Nordisk A/S

NVO

Quality scores

Data as of Sep 5, 2026

3 / 9

Weak

3/9 — WEAK fundamentals (a sign of low quality).

PassROA > 0 — ROA last year = 18.87 %
PassFCF > 0 — FCF last year = 28,989.00 mill.
FailFCF > net income (accrual quality) — FCF 28,989.00 vs. net income 102,434.00 (mill.)
FailRising ROA — ROA 18.87 % vs. prior year 21.69 %

FailLower long-term leverage — long-term debt/assets 0.21 vs. prior 0.18
PassRising current ratio (more liquidity) — Current ratio 0.80 vs. prior 0.74
FailNo dilution (shares do not grow) — Shares 4,443.48 mill. vs. prior 4,441.34 mill.

Z-Score (original)

4.16

Safe zone

Z''-Score (non-manufacturing)

6.15

Safe zone

Ratio	Value
X1 — Working capital / Total assets	-0.08
X2 — Retained earnings / Total assets	0.36
X3 — EBIT / Total assets	0.25
X4 — Market cap / Total liabilities	3.94
X4 — Book equity / Total liabilities	0.56
X5 — Sales / Total assets	0.57